baber/WOPTO huggingface dataset:
Patent AU-2018385435-A1 (AU)
Title: Lithium ion battery
Inventor: LAMPE-ONNERUD MARIA CHRISTINA
IPC: H01G11/06
Filed: 2018-12-07
Abstract: A multi-core lithium ion battery includes a sealed enclosure and a support member disposed within the sealed enclosure. The sealed enclosure may be fabricated with a clamshell configuration. The sealed enclosure may further include at least two support members housed within individual compartments, separated by shared wall(s). The support member(s) includes a plurality of cavities and a plurality of lithium ion core members which are disposed within the plurality of cavities. The battery may further include a plurality of cavity liners, each of which is positioned between a corresponding one of the lithium ion core members and a surface of a corresponding one of the cavities. The hermetically sealed enclosure may be formed using a clamshell configuration. Structures may be included in proximity to or in contact with the lithium ion core members to control gas/fluid flow therefrom.
Patent AU-2018387430-A1 (AU)
Title: Fusion proteins
Inventor: MUSSAI FRANCIS JAY
IPC: C07K14/435
Filed: 2018-12-24
Abstract: Provided are fusion target-binding proteins comprising a target binding moiety, an intracellular signalling region and a domain that promotes synthesis of arginine or an arginine precursor. The domain may be an enzyme domain such as an argininosuccinate synthase (ASS-1) enzyme domain, or an ornithine transcarbamylase (OTC) enzyme domain. Also provided are cells comprising such a fusion target-binding protein (for example cells that express the fusion target-binding protein), and nucleic acids encoding such fusion target-binding proteins. The invention also provides fusion target-binding proteins comprising a target binding moiety, an intracellular signalling region and a domain that promotes synthesis of tryptophan or a tryptophan precursor. Pharmaceutical compositions, medical uses, and methods of treatment, all using the fusion target-binding proteins, cells, or nucleic acids are disclosed. The proteins, cells, nucleic acids and pharmaceutical compositions may be used in the prevention and/or treatment of cancer, such as neuroblastoma or acute myeloid leukaemia.
Patent AU-2018390976-A1 (AU)
Title: Mobile patient support chair
Inventor: MATTERS BRENTON GEORGE
IPC: A61G1/017
Filed: 2018-12-10
Abstract: A mobile patient support chair to assist in bathing of a patient by a carer with little or no upper body strength comprises a chair pivotally mounted in a support frame comprised of four legs each ending in a wheel. The chair frame comprises groups of support panels which can be locked in support positions and rotated through 90 degrees to provide access to the patient's legs, buttocks and back. Additionally the chair is balanced to allow easy rotation into a fully backwards lying position, and a fully forward lying position. In the fully forward lying position flexible retaining strips are placed across the patient to retain them in place. Additionally the wheels may be step-climbing wheels to assist in climbing small steps found in bathroom entrances and shower cubicles.
Patent AU-2018407616-A1 (AU)
Title: Scramjet engine and flying object
Inventor: NAKAMURA MASAHARU
IPC: F02K7/14
Filed: 2018-07-13
Abstract: The purpose of the present invention is to improve the combustion efficiency of a scramjet engine. The scramjet engine is provided with a first and a second flow passageway forming members, and a first and a second fuel injection devices. A flow passageway formed between the first flow passageway forming member and the second flow passageway forming member includes: a turbulence forming region into which compressed air is introduced from upstream; and a combustion region which is positioned downstream of the turbulence forming region and in which combustion using compressed air is performed. The second flow passageway forming member is formed with a protrusion which is positioned in the turbulence forming region and which protrudes toward the first flow passageway forming member. The first fuel injection device injects fuel into the compressed air via a first fuel nozzle provided in the protrusion. The second flow passageway forming member is formed with a cavity positioned in the combustion region. The second fuel injection device injects fuel into the compressed air via a second fuel nozzle provided in the cavity. The cavity includes a bottom surface and an inclined surface connecting to a downstream end of the bottom surface. The inclination of the inclined surface of the cavity is adjusted so as to generate a shock wave in the combustion region.
Patent AU-2019201035-A1 (AU)
Title: Compositions and methods for capture of cellular targets of bioactive agents
Inventor: HITKO CAROLYN W
IPC: A61K39/00
Filed: 2019-02-14
Abstract: The present invention provides compositions and methods for capture and identification of the cellular targets of a bioactive agent. In particular, provided herein are bioactive agents tethered to capture ligand, cellular targets (optionally tagged with a 5 reporter), capture proteins (optionally present as capture fusions), surfaces (e.g., displaying, capture ligands, capture proteins, or capture fusions), and methods of capturing and identifying the cellular targets of a bioactive agent therewith. 6569282_1 (GHMatters) P100158.AU LYNT
Patent AU-2019202203-A1 (AU)
Title: A device management system
Inventor: TRIGGER BENJAMIN SHAUN DIXON
IPC: H04L12/24
Filed: 2019-03-29
Abstract: Abstract A system for managing usage of at least one network enabled device is disclosed. The system comprises a policy storage separately located relative to the user device, 5 the policy database arranged to store information indicative of at least one usage policy set applicable to at least one respective user device, each usage policy set defining usage permissions and/or usage restrictions for a respective user device. The system is arranged to store user device identification information for each user device associated with the system, the user device identification information being indicative 10 of and unique to a user device associated with the system and being stored separately relative to the user device. The system is also arranged to associate a usage policy set with a user device using the device identification information unique to the user device. The system is also arranged to determine a usage request from a user device and to allow or deny the usage request based on the at least one usage policy set 15 associated with the user device.
Patent AU-2019202814-A1 (AU)
Title: Method and system for cooling a hydrocarbon stream using a gas phase refrigerant
Inventor: KRISHNAMURTHY GOWRI
IPC: C10L3/10
Filed: 2019-04-22
Abstract: Described herein are methods and systems for the liquefaction of a natural gas stream using a refrigerant comprising methane or a mixture of methane and nitrogen. The 5 methods and systems use a refrigeration circuit and cycle that employs one or more turbo-expanders to expand one or more streams of gaseous refrigerant to provide one or more streams of at least predominantly gaseous refrigerant that are used to provide refrigeration for liquefying and/or precooling the natural gas, and a J-T valve to expand down to a lower pressure a stream of liquid or two-phase refrigerant to provide a 10 vaporizing stream of refrigerant that provides refrigeration for sub-cooling. - - - - - ------------------- I co L U) (0 I1 CY) I% cN' cco C)v C)) C)V 00 (0 co C.0 N (00 (00
Patent AU-2019202965-A1 (AU)
Title: Techniques for benchmarking pairing strategies in a contact center system
Inventor: CHISHTI ZIA
IPC: H04M3/523
Filed: 2019-04-29
Abstract: Techniques for benchmarking pairing strategies in a contact center system are disclosed. In one particular embodiment, the techniques may be realized as a method for benchmarking pairing strategies in a contact center system comprising: cycling, by at least one processor configured for contact center operations, among at least two pairing strategies; and determining, by the at least one processor, a difference in performance between the at least two pairing strategies, wherein at least one contact was paired in a sequence of contact interactions to reach a final outcome during a final contact interaction of the sequence of contact interactions. Contact Center System Central Switch - 610 Benchmarking Module Contact Center Contact Center A Switch Switch Agent Agent Agent Agent 630A 630B 630C 630D
Patent AU-2019203438-A1 (AU)
Title: Promoting hair growth and treatment of hair loss or excessive hair shedding
Inventor: SINCLAIR RODNEY
IPC: A61P17/14
Filed: 2019-05-16
Abstract: Abstract The present invention relates to methods and compositions for treating hair loss or excessive hair shedding in a subject or for promoting hair growth in a subject. The present invention also relates to an orodispersible composition or a nasally administered composition for treating hair loss or excessive hair shedding in a subject or for promoting hair growth in a subject.
Patent AU-2019204181-A1 (AU)
Title: Novel quinazolinone derivatives inhibiting pi3k and pharmaceutical composition containing same
Inventor: KIM JONG-WOO
IPC: A61K31/517
Filed: 2019-06-14
Abstract: A method of preparing a compound represented by Formula 1 below, the method comprising: preparing a compound represented by Formula 2 below; 5 preparing a compound represented by Formula 3 below; and reacting a compound represented by Formula 2 below with a compound represented by Formula 3 to prepare the compound of Formula 1: x 0 x'-~N y'/N [Formula 1] wherein, in Formula 1, X is -H, halogen, or -CH3; and Y is C3-4 cycloalkyl; x 0 e ~N' N-2NH, 15 [Formula 2] wherein, in Formula 2, X is -H, halogen, or -CH3; and Y is C3 .4 cycloalkyl; z 20 [Formula 3] wherein, in Formula 3, Z is halogen.
Patent AU-2019209164-A1 (AU)
Title: Process for making paper with improved filler retention and opacity while maintaining wet tensile strength
Inventor: LEWIS ASHLEY HAWKINS
IPC: D21H17/55
Filed: 2019-01-10
Abstract: A process is disclosed for making paper having improved filler retention and opacity. The process includes the step of adding Additive A and Additive B to a slurry in a wet end of a paper machine wherein the slurry comprises pulp and a filler. Additive A is a wet strength agent. Additive B is an anionic polymer having a charge density from about -3000 to about -7000 ueq/g on a dry basis when measured in a buffer having a pH of about 6. Additive B also has a weight average molecular weight of from about 150,000 to about 1,000,000, Daltons.
Patent AU-2019233923-A1 (AU)
Title: Systems and methods for treating the nasal cavity
Inventor: FAHEY BRIAN
IPC: A61M31/00
Filed: 2019-03-18
Abstract: The present disclosure provides an apparatus (200) for delivering an anesthetic agent (222) to a target tissue in a nasal cavity (100) of a patient. The apparatus (200) includes an elongated shaft (212) with a proximal end (214) and a distal end (216). The apparatus (200) also includes an absorbent plug (220) coupled to the distal end (216) of the elongated shaft (212). The absorbent plug (220) is configured to occupy a first volume in a compressed state and a second volume in an uncompressed state. The absorbent plug (220) is configured to store an anesthetic agent (222) and deliver the anesthetic agent (222) to the target tissue in the nasal cavity (100) by contacting the target tissue. The apparatus (200) also includes a sheath (224) at least partially covering the absorbent plug (220). The sheath (224) retains the absorbent plug (220) in the compressed state when positioned at least partially over the absorbent plug (220), and removal of the sheath (224) allows for the absorbent plug (220) to expand to the uncompressed state.
Patent AU-2019258509-A1 (AU)
Title: Methods for purification of polypeptides using polysorbates
Inventor: FALKENSTEIN ROBERTO
IPC: C07K1/16
Filed: 2019-04-25
Abstract: Herein is reported a method for purifying a protein from a sample comprising the protein and at least one impurity with hydrolytic activity, comprising the following steps: i) a) applying the sample comprising the protein and at least one impurity with hydrolytic activity to a chromatography material, b) applying a solution which comprises a polysorbate to the chromatography material, and c) recovering the protein from the chromatography material, or ii) a) adding a polysorbate to the sample comprising the protein and at least one impurity with hydrolytic activity, b) applying the mixture of step a) to a chromatography material, and c) recovering the protein from the chromatography material, or iii) a) adding a polysorbate to the sample comprising the protein and at least one impurity with hydrolytic activity, b) applying the mixture of step a) to a chromatography material, c) applying a solution which comprises a polysorbate to the chromatography material, and d) recovering the protein from the chromatography material.
Patent AU-2019268333-A1 (AU)
Title: Treating solid tumors with bromodomain inhibitors
Inventor: ALBERT DANIEL
IPC: A61K31/437
Filed: 2019-05-15
Abstract: The present disclosure relates to methods of treating cancers characterized by the presence of a solid tumor in a human subject by administering an effective amount of mivebresib to the subject.
Patent AU-2019269641-A1 (AU)
Title: CH3 domain epitope tags
Inventor: ROBINSON MATTHEW K
IPC: C07K19/00
Filed: 2019-05-17
Abstract: This invention relates to the incorporation of one, or more, heterologous antibody epitopes into the AB, EF, or CD structural loops of the constant heavy domain 3 ("CH3 domain") of an engineered antibody or Fc-linked therapeutic agent. The heterologous epitopes serve as "epitope tags" that are specifically detectable by epitope tag-specific detector antibodies, irrespective of the tagged agent's target specificity. Therefore, the epitope tags are useful for the rapid detection of any tagged antibody or Fc- linked agent in biological samples, including samples, which also contain endogenous antibodies.
Patent AU-2019284210-A1 (AU)
Title: Amplification method
Inventor: MORLEY ALEXANDER ALAN
IPC: C12Q1/6848
Filed: 2019-06-07
Abstract: The present invention relates generally to an improved method of amplifying a nucleic acid region of interest and to primers for use therein. More particularly, the present invention is directed to an improved method of amplifying a nucleic acid region which has resulted from the recombination of two or more immunoglobulin or T cell receptor gene segments and primers for use therein. The method of the present invention is based on the determination that performing the amplification step using primers which exhibit a high Tm and/or using a high annealing temperature enables higher levels of sensitivity than has previously been achievable in the context of prior art methods of amplifying rearranged immunological or T cell receptor genes. Still further improvements in sensitivity are achievable where the subject primer hybridises to at least two N regions of the recombined gene. The provision of a highly sensitive yet simple means of detecting specific immunological and T cell receptor nucleic acid recombination events is useful in a range of applications including, but not limited to, the diagnosis and/or monitoring of clonal lymphoid cell populations or disease conditions which are characterised by specific V/D/J recombination events (such as detecting minimal residual disease in leukaemias) or the analysis or identification of immunological or T cell receptor gene regions of interest.
Patent AU-2019315689-A1 (AU)
Title: Inverter comprising intermediate circuit protection
Inventor: OBERZAUCHER FRIEDRICH
IPC: H02M7/48
Filed: 2019-07-30
Abstract: An inverter (1) having a DC/DC converter (4), which converts a direct voltage received from a direct-voltage source (3) into a DC link voltage of a DC link (5), a DC/AC converter (6), which converts the DC link voltage into an alternating voltage, having a monitoring unit (8), which monitors capacitors of the DC link (5) in order to protect against overvoltages, the monitoring unit (8) decoupling the direct voltage source (3) from the DC link (5) by controlling the DC/DC converter (4) in the event that an overvoltage occurs on at least one of the capacitors of the DC link (5).
Patent AU-2019330752-A1 (AU)
Title: A hybrid accommodating intra-ocular lens and method of use thereof
Inventor: WEBB GARTH T
IPC: G02B3/14
Filed: 2019-08-29
Abstract: An intra-ocular lens having an air-filled collapsible cavity situated between two optical elements wherein air is transferred from optical regions of the collapsible cavity to its peripheral haptic regions after being compressed by external force.
Patent AU-2019384064-A1 (AU)
Title: Aryl-aniline and heteroaryl-aniline compounds for treatment of birthmarks
Inventor: KINCAID JOHN
IPC: A61K31/166
Filed: 2019-11-20
Abstract: Provided herein are compounds and pharmaceutical compositions thereof for treating a birthmark in a subject in need thereof, wherein the compound is according to any one of formula (1), (II), (III), (IV), and (V). wherein X
Patent AU-2019423025-A1 (AU)
Title: Air conditioning system
Inventor: KAWAI TOMOFUMI
IPC: F24F11/58
Filed: 2019-12-19
Abstract: An air conditioning system comprises an air conditioner, and an adapter that connects the air conditioner and an external server device. The adapter has a first update unit and a second update unit. If a new learning model that provides a recommended operation to a control unit of the air conditioner is received from the external server device, the first update unit updates the learning model using a first update method. If an update control program that updates a control program of the air conditioner is received from the external server device, the second update unit updates the update control program using a second update method that differs from the first update method. The adapter load can be reduced by updating the learning model and the control program using different methods.
Patent WO-2020146919-A1 (WO)
Inventor: DUNLOP COLIN
IPC: A61M16/18
Filed: 2020-01-16
Abstract: A filler for an anaesthetic vaporizer used for veterinary surgery. The filler is attached to a cylindrical bucket portion of the vaporizer. The filler is curved in shape and having a concave mounting surface that is obverse to the cylindrical bucket portion. The filler having fluid conduits therein interconnecting first apertures on the concave mounting concave surface and a filler-port unit, the first apertures on the mounting surface aligning with associated second apertures on said bucket. A gasket with a plurality of first holes aligned with first and second apertures is disposed between the bucket and the filler.
Patent WO-2020237283-A1 (WO)
Inventor: WANG ZHIYAO
IPC: C02F3/34
Filed: 2020-03-27
Abstract: A method for treating wastewater or sludge comprises the steps of adding the wastewater or sludge to a reactor and mixing the wastewater or sludge with a stream to thereby decrease a ratio of alkalinity to ammonium in the reactor, the reactor containing ammonium oxidising bacteria that oxidise ammonium to produce nitrite and decrease pH.
Patent AU-2020201738-A1 (AU)
Title: Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same
Inventor: YAMAGUCHI HIDEAKI
IPC: A61P35/00
Filed: 2020-03-10
Abstract: Provided is a free-polyunsaturated-fatty-acid-containing composition that has a total metal content of 0.1 ppm or less and that comprises at least one free polyunsaturated fatty acid having 20 or more carbon atoms, in an amount that is at least 80.0% of the amount of fatty acids in the composition; and a method for manufacturing a free-polyunsaturated-fatty-acid-containing composition, comprising: providing a raw material composition containing at least one polyunsaturated fatty acid having 20 or more carbon atoms; performing a hydrolysis treatment on a reaction solution prepared by combining the provided raw material composition, a lower alcohol, water having a total metal content of 0.01 ppm or less, and an alkali catalyst; and limiting the contact between the reaction composition and the metal after the hydrolysis treatment so that the product T [cm2 x days] of the contact surface area [cm2 ] per 1 g and the contact time [days] between the composition and the metal is 100 or less.
Patent AU-2020203196-A1 (AU)
Title: Combination therapies and uses for treatment of demyelinating disorders
Inventor: DIEGO CADAVID
IPC: C07K16/28
Filed: 2020-05-15
Abstract: Methods and compositions for enhancing one or more of: myelination, re-myelination, oligodendrocyte numbers, or neuroaxonal protection, while ameliorating an inflammatory condition in a human subject are disclosed. In certain embodiments, the methods and compositions described herein include a reparative agent (e.g., a LINGO-I antagonist) and an immunomodulatory agent, in combination. Thus, methods, compositions and kits described herein can be useful for treating a CNS demyelinating disease.
Patent AU-2020203283-A1 (AU)
Title: Devices and systems to mitigate traumatic brain and other injuries caused by concussive or blast forces
Inventor: SMITH DAVID W
IPC: A61B17/135
Filed: 2020-05-20
Abstract: DEVICES AND SYSTEMS TO MITIGATE TRAUMATIC BRAIN AND OTHER INJURIES CAUSED BY CONCUSSIVE OR BLAST FORCES Abstract A system for reducing the damaging effects of radiant energy, blast, or concussive 5 events includes applying pressure to at least one jugular vein to reduce the egress of blood from the cranial cavity during or before the incidence of the imparting event. Reducing blood outflow from the cranial cavity increases intracranial volume and/or pressure of the cerebrospinal fluid to reduce the risk of traumatic brain injury and injuries to the spinal column. Reducing blood outflow further increases the intracranial pressure and volume, and .0 thereby increases the pressure and volume of the cochlear fluid, the vitreous humor and the cerebrospinal fluid to thereby reduce the risk of injury to the inner ear, internal structure of the eye and of the spinal column. In addition, increasing intracranial pressure and volume reduces the likelihood of brain injury and any associated loss of olfactory function.
Patent AU-2020207027-A1 (AU)
Title: System and method for perturbing a permanent magnet asymmetric field to move a body
Inventor: CLYMER MARK LAWRENCE
IPC: H01F7/02
Filed: 2020-03-09
Abstract: A system and method for perturbing a permanent magnet asymmetric field to move a body includes a rotating body configured to rotate about a rotation axis, a permanent magnet arrangement arranged on the rotating body containing two or more permanent magnets, and a perturbation element. The permanent magnet arrangement is configured such that an asymmetric magnetic field is generated by the permanent magnets about a perturbation point. Actuation of the perturbation element at or near the perturbation point causes a tangential magnetic force on the rotating body and/or the permanent magnet arrangement, thereby causing the rotating body to rotate about the rotation axis. The disclosure may also be used for linear motion of a body.
Patent AU-2020207864-A1 (AU)
Title: Production of fine-pored PMMA foams using nucleating agents
Inventor: RICHTER THOMAS
IPC: C08J9/00
Filed: 2020-07-24
Abstract: 5 The present invention relates to novel types of fine-cell PMMA foams and also to the production 
thereof. The recipes used in the production process include nucleators in addition to suitable 
blowing agents. It was found that, surprisingly, the invention provides a simple-to-produce stable 
PMMA foam having very fine cells and very good properties.